Suppr超能文献

非增生性狼疮性肾炎患者的长期肾脏结局。

Long-term renal outcomes of patients with non-proliferative lupus nephritis.

机构信息

Division of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Information Medicine, Big Data Research Center, Asan Medical Center, Seoul, Korea.

出版信息

Korean J Intern Med. 2023 Sep;38(5):769-776. doi: 10.3904/kjim.2022.339. Epub 2023 Aug 7.

Abstract

BACKGROUND/AIMS: Although non-proliferative lupus nephritis (LN) (class I, II or V) has been considered as a less severe type of LN, data on long-term renal prognosis are limited. We investigated the long-term outcomes and prognostic factors in non-proliferative LN.

METHODS

We retrospectively reviewed patients with systemic lupus erythematosus who were diagnosed with LN class I, II, V, or II + V by kidney biopsy from 1997 to 2021. A poor renal outcome was defined as an estimated glomerular filtration rate (eGFR) of < 60 mL/min/1.73 m2.

RESULTS

We included 71 patients with non-proliferative LN (class I = 4; class II = 17; class V = 48; class II+V = 2), and the overall rate of poor renal outcomes was 29.6% (21/71). The univariate analysis indicated that older age, low eGFR at 6 or 12 months, failure to reach complete remission at 6 months, and LN chronicity score > 4 or activity score > 6 were significantly associated with poor renal outcomes. The multivariate analysis revealed that low eGFR at 6 months (HR 0.971, 95% CI 0.949-0.991; p = 0.014) was significantly associated with poor renal outcomes.

CONCLUSION

Poor renal outcomes occurred in approximately 30% of patients with non-proliferative LN after long-term follow-up. More active management may be needed for non-proliferative LN, especially for patients with eGFR < 60 mL/ min/1.73 m2 at 6 months follow-up after LN diagnosis.

摘要

背景/目的:尽管非增生性狼疮肾炎(LN)(I 型、II 型或 V 型)被认为是一种较轻的 LN 类型,但关于其长期肾脏预后的数据有限。我们研究了非增生性 LN 的长期结局和预后因素。

方法

我们回顾性分析了 1997 年至 2021 年期间经肾活检诊断为 LN I 型、II 型、V 型或 II+V 型的系统性红斑狼疮患者。肾功能不良结局定义为估计肾小球滤过率(eGFR)<60 mL/min/1.73 m2。

结果

我们纳入了 71 例非增生性 LN 患者(I 型=4 例,II 型=17 例,V 型=48 例,II+V 型=2 例),总体肾功能不良结局发生率为 29.6%(21/71)。单因素分析表明,年龄较大、6 或 12 个月时 eGFR 较低、6 个月时未达到完全缓解、LN 慢性评分>4 或活动评分>6 与肾功能不良结局显著相关。多因素分析显示,6 个月时 eGFR 较低(HR 0.971,95%CI 0.949-0.991;p=0.014)与肾功能不良结局显著相关。

结论

在长期随访中,约 30%的非增生性 LN 患者出现肾功能不良结局。对于非增生性 LN,特别是在 LN 诊断后 6 个月 eGFR<60 mL/min/1.73 m2 的患者,可能需要更积极的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c5e/10493439/676f13cae7e5/kjim-2022-339f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验